免疫调节用于治疗散播性菌菌菌症
Alexis V Stephens1, Timothy J Thauland2, Gregory D Whitehill3
1Department of Human Genetics, UCLA, Los Angeles, California, USA.
免疫调节与抗真菌药物相结合显示出治疗严重的菌菌菌的前景. 这种方法改善了88%的患者的生存率,这表明了这种严重的真菌感染的潜在新治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 临床医学 临床医学
背景情况:
- 尽管目前的抗真菌治疗方法,传播性菌菌有很高的死亡率.
- 免疫调节被提议作为一种辅助疗法,以改善临床结果.
- 之前的研究表明,干扰素玛或dupilumab的潜在益处.
研究的目的:
- 评估免疫调节疗法的有效性,作为严重或持续性菌菌病的辅助治疗.
- 评估干扰素玛和杜皮卢马布对患者结局的影响.
主要方法:
- 一个由18名患有严重/持续性菌菌病的患者组成的病例系列,接受最大抗真菌治疗.
- 根据临床背景和T辅助细胞细胞因子 (干扰素马与IL-4) 的特征选择免疫调节治疗方案.
- 干扰素玛治疗严重疾病;杜皮卢马布治疗2型免疫失调.
主要成果:
- 杜皮卢马布治疗导致2型T细胞反应减少.
- 在18名患者中,有16名 (88%) 幸存下来.
- 与基线相比,大多数患者的临床结果有所改善.
结论:
- 免疫调节可能有利于患有严重和/或扩散性菌菌病的患者.
- 这些发现支持对干扰素玛和杜皮卢马布的非标签使用.
- 对干扰素玛 (严重疾病) 和dupilumab (具有2型免疫失调的传播疾病) 进行临床试验是有必要的.
更多相关视频
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
